Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...

The disruption is expected to impact patient care, may require adjustments to the management of hemodialysis patients and ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

Thanks to an enterprising group of Canadian college students, you may soon be able to grow your own GLP-1 drugs.

On February 21, 2025, the US Food and Drug Administration (FDA) revised its shortage categorization of semaglutide, a glucagon-like peptide 1 ...

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...